⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Biogen Inc (0R1B)

London
Currency in USD
159.89
+159.89(+100,000.00%)
Real-time Data

0R1B Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa14,377.913,444.610,981.710,173.49,835.6
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+6.88%-6.49%-18.32%-7.36%-3.32%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,955.41,805.22,109.72,278.32,533.4
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa12,422.511,639.48,8727,895.17,302.2
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+6.75%-6.3%-23.78%-11.01%-7.51%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa86.4%86.57%80.79%77.61%74.24%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa5,147.36,988.35,436.34,876.65,420
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-2.37%+35.77%-22.21%-10.3%+11.14%
aa.aaaa.aaaa.aaaa.aaaa.aa2,272.83,984.62,4972,228.72,458.3
aa.aaaa.aaaa.aaaa.aaaa.aa2,358.92,515.72,680.12,4092,502.3
aa.aaaa.aaaa.aaaa.aaaa.aa241.6232.97.2-7.4218.8
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,275.24,651.13,435.73,018.51,882.2
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.32%-36.07%-26.13%-12.14%-37.64%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa50.6%34.59%31.29%29.67%19.14%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-67.4-171.1-239.4-157.329.6
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+23.5%-153.86%-39.92%+34.29%+118.82%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-187.4-213.1-250.4-246.6-246.9
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa120421189.3276.5
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-130.82.48.5-40-52.1
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,0774,482.43,204.82,821.21,859.7
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-55.392.5-503.7-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-152.2-207.8-599.8-827.5-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,046.55,052.81,780.13,594.41,296.8
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+19.44%-28.29%-64.77%+101.92%-63.92%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa49.01%37.58%16.21%35.33%13.18%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,158992.352.5632.8135.3
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa5,888.54,060.51,727.62,961.61,161.5
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa--59.9-171.585.3-0.4
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa5,888.54,000.61,556.13,046.91,161.1
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+32.9%-32.06%-61.1%+95.8%-61.89%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa40.96%29.76%14.17%29.95%11.81%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa5,888.54,000.61,556.13,046.91,161.1
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa31.4724.8610.4420.978.02
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+45.55%-21%-58.02%+100.92%-61.73%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa31.4224.810.420.877.97
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+45.6%-21.07%-58.06%+100.67%-61.81%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa187.1160.9149.1145.3144.7
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa187.4161.3149.6146145.6
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa7,739.95,108.33,923.43,536.92,377
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa